医学临床研究
  2025年5月10日 星期六           首 页    |    期刊简介    |    编委会    |    投稿指南    |    期刊订阅    |    广告合作    |    留言板    |    联系我们    |    English
医学临床研究  2022, Vol. 39 Issue (11): 1698-1701    DOI: 10.3969/j.issn.1671-7171.2022.11.028
  论著 本期目录 | 过刊浏览 | 高级检索 |
清热凉血汤联合NB-UVB治疗血虚风热型白癜风患者的临床疗效
张霞1, 雷雅丽2*
1.杨凌示范区医院皮肤科,陕西 杨凌 712100;
2.宝鸡市解放军联勤保障部队第九八七医院皮肤科,陕西 宝鸡 721004
Clinical Study of Qingre Liangxue Decoction Combined with NB-UVB in Treating Vitiligo with Blood Deficiency and Wind-heat Type
ZHANG Xia, LEI Ya-li
Department of Dermatology,Yangling Demonstration Area Hospital,Yangling Shaanxi 712100
全文: PDF (1159 KB)   HTML (1 KB) 
输出: BibTeX | EndNote (RIS)      
摘要 【目的】探讨清热凉血汤联合窄谱中波紫外线(NB-UVB)治疗血虚风热型白癜风患者的临床价值。【方法】选取2017年1月至2021年9月在杨凌示范区医院皮肤科门诊就诊的90例白癜风患者,按随机数字表法分为观察组和对照组,两组45例。对照组患者采用NB-UVB治疗,观察组患者在对照组基础上加服清热凉血汤,两组均治疗6周。比较两组患者临床疗效、治疗期间不良反应及治疗前后中医证候积分、CXC趋化因子配体16(CXCL16)、转化生长因子-β1(TGF-β1)、白介素-26(IL-26)、T淋巴细胞(CD4+、CD8+及CD4+/CD8+)。【结果】观察组总有效率为93.33%,显著高于对照组的77.78%(P<0.05);两组治疗后局部白斑、面色淡白、食欲不振、头晕眼花、心悸失眠、乏力评分显著低于治疗前(P<0.05),且观察组治疗后上述症状评分显著低于对照组(P<0.05);两组治疗后CXCL16、TGF-β1、IL-26水平显著低于治疗前(P<0.05),且观察组治疗后CXCL16、TGF-β1、IL-26水平显著低于对照组(P<0.05);两组治疗后CD4+、CD4+/CD8+显著高于治疗前,CD8+显著低于治疗前(P<0.05),且观察组治疗后CD4+、CD4+/CD8+显著高于对照组,CD8+显著低于对照组(P<0.05);两组治疗期间不良反应总发生率比较,差异无统计学意义(P>0.05)。【结论】清热凉血汤联合NB-UVB治疗血虚风热型白癜风疗效好,可有效缓解患者的临床症状,抑制炎症反应,调节免疫功能,且安全性好,值得临床推广应用。
服务
把本文推荐给朋友
加入我的书架
加入引用管理器
E-mail Alert
RSS
作者相关文章
张霞
雷雅丽
关键词 白癜风/治疗紫外线疗法治疗结果    
Abstract:【Objective】To explore the clinical value of Qingre Liangxue Decoction combined with narrow-band ultraviolet (NB-UVB) in the treatment of vitiligo showing blood deficiency and wind-heat type. 【Methods】 A total of 90 patients with vitiligo who visited Yangling Demonstration Area Hospital dermatology clinic from January 2017 to September 2021 were selected as the study subjects. Patients were divided into the observation group and the control group according to the random number table method, with 45 cases in each group. Patients in the control group were treated with NB-UVB, and patients in the observation group were treated with Qingre liangxue Decoction on the basis of the control group. The treatment period of both groups was 6 weeks. The treatment effects and adverse reactions during the treatment were compared between the two groups of patients. The scores of TCM syndromes, CXC chemokine ligand 16 (CXCL16), transforming growth factor-β1 (TGF-β1), Interleukin-26 (IL-26) and T lymphocytes (CD4+, CD8+ and CD4+/CD8+) were compared between the two groups before and after treatment. 【Results】The total effective rate of the observation group was 93.33%, which was significantly higher than that of the control group 77.78% (P<0.05).The scores of local leukoplakia, pale complexion, loss of appetite, dizziness, palpitations, insomnia, and fatigue after treatment in the two groups were significantly lower than those before treatment (P<0.05).After treatment, the observation group's local leukoplakia, pale complexion, loss of appetite, dizziness, palpitations, insomnia, and fatigue scores were significantly lower than those of the control group (P<0.05).The levels of CXCL16, TGF-β1 and IL-26 after treatment in the two groups were significantly lower than those before treatment (P<0.05). After treatment, levels of CXCL16, TGF-β1, and IL-26 in the observation group were significantly lower than those in the control group (P<0.05). CD4+, CD4+/CD8+ after treatment in the two groups were significantly higher than those before treatment, while CD8+ was significantly lower than before treatment (P<0.05).After treatment, CD4+, CD4+/CD8+ in the observation group were significantly higher than those in the control group, while CD8+ in the observation group was significantly lower than that in the control group (P<0.05).There was no statistically significant difference in the total incidence of adverse reactions between the two groups during treatment (P>0.05). 【Conclusion】The combination of Qingre Liangxue Decoction and NB-UVB has a good therapeutic effect in the treatment of blood deficiency and wind-heat type vitiligo. It can effectively relieve the patient's clinical symptoms, inhibit inflammation, regulate immune function, and has good safety.
Key wordsVitiligo/TH    Ultraviolet Therapy    Treatment Outcome
收稿日期: 2021-11-12     
中图分类号:  R758.41  
通讯作者: *E-mail:liya5672@163.com   
引用本文:   
张霞, 雷雅丽. 清热凉血汤联合NB-UVB治疗血虚风热型白癜风患者的临床疗效[J]. 医学临床研究, 2022, 39(11): 1698-1701.
ZHANG Xia, LEI Ya-li. Clinical Study of Qingre Liangxue Decoction Combined with NB-UVB in Treating Vitiligo with Blood Deficiency and Wind-heat Type. JOURNAL OF CLINICAL RESEARCH, 2022, 39(11): 1698-1701.
链接本文:  
http://journal07.magtech.org.cn/yxlcyj/CN/10.3969/j.issn.1671-7171.2022.11.028     或     http://journal07.magtech.org.cn/yxlcyj/CN/Y2022/V39/I11/1698
版权所有 © 2013 医学临床研究杂志社  湘ICP备13012052号-1
办公地址:湖南省长沙市芙蓉区新军路43号煤炭大院主办公楼6楼621、623、632、636室 邮编:410011 电话(传真):0731-84824007 E-mail:jcr_cs.hn@vip.163.com
技术支持:北京玛格泰克科技发展有限公司 技术支持:support@magtech.com.cn